[Experience with movalis administration against osteoarthritis in Moscow clinics].
To test effectiveness of a new nonsteroid antiinflammatory drug movalis in osteoarthritis. 113 patients aged 30-85 years from 8 Moscow clinics were treated with movalis. All the patients had long-standing osteoarthritis, 26 patients had concomitant gastric or duodenal ulcers. Movalis was given in daily dose from 7.5 to 15 mg for 1-4 weeks. None case of ulcer onset or recurrence was observed. The response was rated as good in 44.2, satisfactory in 47.0% and bad in 8.8% of the cases. Tolerance was good in 99.1% of patients and bad in 0.9%. Movalis has a definite antiinflammatory and analgetic activity in patients with osteoarthritis and spondylarthrosis.